Biblio

Export 372 results:
Author Keyword [ Title(Desc)] Type Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
L. García Barrado, Coart, E., Vanderstichele, H. M. J., and Burzykowski, T., Transferring cut-off values between assays for cerebrospinal fluid Alzheimer's disease biomarkers., J Alzheimers Dis, vol. 49, no. 1, pp. 187-99, 2016.
R. Guerreiro, Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. - C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J., TREM2 variants in Alzheimer's disease., N Engl J Med, vol. 368, no. 2, pp. 117-27, 2013.
M. A. Beydoun, Gamaldo, A. A., Beydoun, H. A., Shaked, D., Zonderman, A. B., and Eid, S. M., Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample., J Alzheimers Dis, vol. 57, no. 3, pp. 813-824, 2017.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
U
K. Muthukumaran, Kanwar, A., Vegh, C., Marginean, A., Elliott, A., Guilbeault, N., Badour, A., Sikorska, M., Cohen, J., and Pandey, S., Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
T. Nikolai, Stepankova, H., Kopecek, M., Sulc, Z., Vyhnálek, M., and Bezdicek, O., The Uniform Data Set, Czech Version: Normative Data in Older Adults from an International Perspective., J Alzheimers Dis, vol. 61, no. 3, pp. 1233-1240, 2018.
M. A. Schilling, Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1., J Alzheimers Dis, vol. 51, no. 4, pp. 961-77, 2016.
B. Seok Ye, Jang, E. Young, Kim, S. Yoon, Kim, E. - J., Park, S. Ah, Lee, Y., Hong, C. Hyung, Choi, S. Hye, Yoon, B., Yoon, S. Jin, Na, H. Ri, Lee, J. - H., Jeong, J. H., Kim, H. Jin, Na, D. L., and Seo, S. Won, Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment., J Alzheimers Dis, vol. 49, no. 2, pp. 483-91, 2016.
C. Marra, Gainotti, G., Fadda, L., Perri, R., Lacidogna, G., Scaricamazza, E., Piccininni, C., and Quaranta, D., Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS)., J Alzheimers Dis, vol. 50, no. 1, pp. 61-70, 2016.
V
X. Feng, Zhou, A., Liu, Z., Li, F., Wei, C., Zhang, G., and Jia, J., Validation of the Delayed Matching-to-Sample Task 48 (DMS48) in Elderly Chinese., J Alzheimers Dis, vol. 61, no. 4, pp. 1611-1618, 2018.
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., Validation of the Spanish version of the Baylor Profound Mental Status Examination., J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
A. L. Jefferson, Gifford, K. A., Mae Y Acosta, L., Bell, S. P., Donahue, M. J., L Davis, T., Gottlieb, J. A., Gupta, D. K., Hohman, T. J., Lane, E. M., Libon, D. J., Mendes, L. A., Niswender, K., Pechman, K. R., Rane, S., Ruberg, F. L., Su, Y. Ru, Zetterberg, H., and Liu, D., The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview., J Alzheimers Dis, vol. 52, no. 2, pp. 539-59, 2016.
J. Li, Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., and Zhou, H. D., Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease., Neurology, vol. 76, no. 17, pp. 1485-91, 2011.
R. Harris, Miners, J. Scott, Allen, S., and Love, S., VEGFR1 and VEGFR2 in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 741-752, 2018.
E. X. Wei, Oh, E. S., Harun, A., Ehrenburg, M., and Agrawal, Y., Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 995-1003, 2018.
S. E. Leh, Kälin, A. M., Schroeder, C., Park, M. Tae M., M Chakravarty, M., Freund, P., Gietl, A. F., Riese, F., Kollias, S., Hock, C., and Michels, L., Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment., J Alzheimers Dis, vol. 49, no. 1, pp. 237-49, 2016.

Pages